# Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

Study · id `cardio:ct-nct06099730` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06099730](<https://clinicaltrials.gov/study/NCT06099730>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06099730

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 442 participants.

## Technical summary

Registry record NCT06099730. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-14 (actual); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 442 participants (planned count; ClinicalTrials.gov record NCT06099730, source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)
- Started: 2023-12-14 (actual) (ClinicalTrials.gov record NCT06099730, source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06099730, source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06099730, source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06099730, source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06099730-2026-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
- Acronym: POLARIS
- Condition: Atrial Fibrillation
- Intervention (Device): Pulsed Field Ablation (PFA)
- Lead sponsor: Massachusetts General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 26a0685c9cc34f39f878f04290a59d89d0966da5fddaeadb3b8f3851fee8a9ea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
